Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRI
CRI logo

CRI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Carter's Inc (CRI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
42.950
1 Day change
-0.88%
52 Week Range
44.440
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Carter's Inc is not a strong buy at the moment for a long-term beginner investor. While there are some positive catalysts, the lack of strong proprietary trading signals, mixed analyst ratings, and limited financial data suggest a cautious approach. The stock's recent upward movement and potential tariff benefits are encouraging, but the lack of significant growth prospects and uncertainty surrounding the CEO transition make it prudent to hold rather than buy.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 69.296, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 42.971 and 44.446, with support at 38.196 and 36.721. Overall, the technical indicators suggest a bullish short-term trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market. However, the implied volatility rank is low at 1.67, suggesting limited market excitement.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • Appointment of a new CEO with a focus on restoring profitability.

  • Potential tariff policy changes that could improve earnings and gross margins.

  • Direct-to-consumer growth strategies showing promise.

Neutral/Negative Catalysts

  • Uncertainty surrounding the CEO transition.

  • Limited long-term growth potential as noted by analysts.

  • Mixed analyst ratings and cautious outlooks.

Financial Performance

No financial data available for the latest quarter. However, analysts have highlighted a strong Q1 performance and improving business momentum.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. Wells Fargo recently upgraded the stock to Equal Weight with a price target of $42, citing improved leadership and direct-to-consumer growth. UBS raised the price target to $41 but maintained a Neutral rating due to uncertainties. Goldman Sachs upgraded the stock to Neutral from Sell, citing opportunities in digital marketing and targeting higher-income consumers.

Wall Street analysts forecast CRI stock price to fall
3 Analyst Rating
Wall Street analysts forecast CRI stock price to fall
1 Buy
0 Hold
2 Sell
Moderate Sell
Current: 43.330
sliders
Low
25
Averages
34.67
High
50
Current: 43.330
sliders
Low
25
Averages
34.67
High
50
Wells Fargo
Underweight -> Equal Weight
upgrade
$30 -> $42
AI Analysis
2026-06-17
Reason
Wells Fargo
Price Target
$30 -> $42
AI Analysis
2026-06-17
upgrade
Underweight -> Equal Weight
Reason
Wells Fargo upgraded Carter's to Equal Weight from Underweight with a price target of $42, up from $30. The firm cites the company's "improved leadership" but the new CEO, direct-to-consumer growth and "underappreciated" tariff upside for the upgrade. Carter's new leadership and "evolved" direct-to-consumer strategies are driving fundamental improvements in the model, the analyst tells investors in a research note. Wells also believes the company's inorganic upside from lower tariff rates is "very underappreciated." The firm sees Carter's upcoming fiscal Q2 results as a positive catalyst for the stock.
UBS
Neutral
maintain
$40 -> $41
2026-05-11
Reason
UBS
Price Target
$40 -> $41
2026-05-11
maintain
Neutral
Reason
UBS raised the firm's price target on Carter's to $41 from $40. Carter's posted a strong first quarter and improving business momentum, but a Neutral rating remains appropriate given uncertainty surrounding the CEO transition, input cost pressures, and limited long-term growth potential, with the current valuation appearing fair, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRI
Unlock Now

People Also Watch